Upcoming Events.
The Citizens Life Sciences Conference
New York, NY
Date/Time: Thursday, 8 May 2025 at 1.00pm ET
BIONNALE 2025
Berlin, Germany
ASCO 2025 Annual Meeting
Chicago, IL, USA
Jefferies Global Healthcare Conference
New York, NY
2025 BIO International Convention
Boston, MA, USA
ESMO Congress 2025
Berin, Germany
Past Events.
Jones Healthcare and Technology Innovation Conference
Las Vegas, NV
Date/Time: Wednesday, 9 April 2025 at 4:30pm ET
European Lung Cancer Congress (ELCC) 2025
Paris, France
BIO-Europe Spring
Milan, Italy
Australian Lung Cancer Congress (ALCC) 2025
Adelaide, Australia
J.P. Morgan 43rd Annual Healthcare Conference
Immutep management will be hosting meetings between January 13-16, 2025, in San Francisco, California
Baird's Biotech Discovery Series Webcast
Date/Time: Thursday, 19 December 2024 at 10:15 AM ET
ESMO Immuno-Oncology Congress 2024
Geneva, Switzerland
Annual General Meeting 2024
Immutep Annual General Meeting 2024 will be taking place at Offices of Piper Alderman, Level 23, Governor Macquarie Tower, 1 Farrer Place, Sydney, NSW 2000 on Friday, 22 November 2024 at 10.30 am (AEDT)
Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting
San Diego, California, USA
BIO-Europe 2024
Stockholm, Sweden
2024 Maxim Healthcare Virtual Summit
Date: Wednesday, October 16
Time: 9:30AM ET
Link to replay
ESMO Congress 2024
Barcelona, Spain
Baird Global Healthcare Conference 2024
New York, NY, USA
Canaccord Genuity 44th Annual Growth Conference
Boston, MA, USA
Date/Time: Wednesday, 14 August at 8:30am ET
Link to Webcast
Global Webcast Presentation for TACTI-003 Positive Data in Patients with Negative PD-L1 Expression (Cohort B)
Executive Director and CEO Marc Voigt, Chief Medical Officer Dr Florian Vogl, and Senior Vice President Strategic Development Christian Mueller presented on Immutep's new clinical data
Date/Time: Friday, July 12, at 9am AEST (7pm ET July 11)
ESMO Virtual Plenary
Virtual Meeting
TACTI-003 Topline Data Update for Patients with Any PD-L1 Expression (Cohort A) & Negative PD-L1 Expression (Cohort B) in 1L HNSCC and Overview of TACTI-004 Pivotal Phase III in 1L NSCLC
Executive Director and CEO Marc Voigt, Chief Scientific Officer Professor Frédéric Triebel, Chief Medical Officer Dr Florian Vogl, and Senior Vice President Strategic Development Christian Mueller presented on Immutep's latest clinical results
Date/Time: Thursday, 27 June 2024 at 9:00am AEST (Wednesday, June 26th, at 7PM ET)
2024 BIO International Convention
San Diego, CA, USA
ASCO 2024 Annual Meeting
McCormick Place, Chicago, IL, USA and Online
ESMO Breast Cancer 2024
Berlin, Germany